Dose-response relationship in phase I clinical trials: A European Drug Development Network (EDDN) collaboration study.
P. A. Cassier
No relevant relationships to disclose
V. Moreno Garcia
No relevant relationships to disclose
C. Gomez-Roca
No relevant relationships to disclose
D. Olmos
No relevant relationships to disclose
R. Morales
No relevant relationships to disclose
G. Del Conte
No relevant relationships to disclose
E. Gallerani
No relevant relationships to disclose
A. Brunetto
No relevant relationships to disclose
P. Schoffski
No relevant relationships to disclose
S. Marsoni
No relevant relationships to disclose
J. H. M. Schellens
No relevant relationships to disclose
N. Penel
No relevant relationships to disclose
E. E. Voest
No relevant relationships to disclose
T. R. J. Evans
No relevant relationships to disclose
R. Plummer
No relevant relationships to disclose
R. H. Wilson
No relevant relationships to disclose
J. Soria
No relevant relationships to disclose
J. Tabernero
No relevant relationships to disclose
J. Verweij
No relevant relationships to disclose
S. B. Kaye
No relevant relationships to disclose